Thermo Fisher Scientific (TMO) Revenue (2009 - 2026)

Thermo Fisher Scientific has reported Revenue for 18 years, with the latest figure at $12.0 billion in Q2 2026.

• Revenue for Q2 2026 came in at $12.0 billion, up 10.49% year-over-year; the trailing twelve-month figure through Jun 2026 was $46.3 billion (up 7.23% YoY), and the FY2025 annual result was $44.6 billion, up 3.91% from the prior year.
• Revenue grew to $12.0 billion in Q2 2026, from $11.0 billion in the prior quarter.
• Over five years, Revenue peaked at $12.2 billion in Q4 2025 and troughed at $10.3 billion in Q1 2024.
• A 5-year average of $11.0 billion and a median of $10.9 billion in 2023 frame the typical range for Revenue.
• The widest annual swing landed in 2022, when Revenue advanced 19.3%; it then slipped 9.38% in 2023.
• A 5-year view of Revenue shows it stood at $11.5 billion in 2022, then decreased by 4.93% to $10.9 billion in 2023, then climbed by 4.68% to $11.4 billion in 2024, then increased by 7.2% to $12.2 billion in 2025, then retreated by 1.81% to $12.0 billion in 2026.
• Per Business Quant data, the three most recent Revenue figures were $12.0 billion in Q2 2026, $11.0 billion in Q1 2026, and $12.2 billion in Q4 2025.